title: Re: Neutralizing antibodies to interferon beta-1b are not associated with disease worsening in multiple sclerosis.
authors.forename: Rachel
authors.initials: R
authors.lastname: Farrell
authors.forename: Klaus
authors.initials: K
authors.lastname: Bendtzen
authors.forename: Antonio
authors.initials: A
authors.lastname: Bertolotto
authors.forename: Berwyn
authors.initials: B
authors.lastname: Clark
authors.forename: Manuel
authors.initials: M
authors.lastname: Comabella
authors.forename: Florian
authors.initials: F
authors.lastname: Deisenhammer
authors.forename: Anna
authors.initials: A
authors.lastname: Fogdell-Hahn
authors.forename: Gavin
authors.initials: G
authors.lastname: Giovannoni
authors.forename: Hans Peter
authors.initials: HP
authors.lastname: Hartung
authors.forename: Bernard
authors.initials: B
authors.lastname: Hemmer
authors.forename: Jan
authors.initials: J
authors.lastname: Hillert
authors.forename: Ludwig
authors.initials: L
authors.lastname: Kappos
authors.forename: Joep
authors.initials: J
authors.lastname: Killestein
authors.forename: Raija
authors.initials: R
authors.lastname: Lindberg
authors.forename: Xavier
authors.initials: X
authors.lastname: Montalban
authors.forename: Chris
authors.initials: C
authors.lastname: Polman
authors.forename: Per Soelberg
authors.initials: PS
authors.lastname: Sorensen
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D019138:Antibodies, Blocking / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D000068576:Interferon beta-1b; D016899:Interferon-beta / Q000276:immunology*; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000276:immunology; D009500:Neutralization Tests; D016896:Treatment Outcome
chemical_list: D000276:Adjuvants, Immunologic; D019138:Antibodies, Blocking; D000068576:Interferon beta-1b; D016899:Interferon-beta